Clinical Trials Browser

Triple Negative Breast Neoplasms

Lymphoma, Large B-Cell, Diffuse

Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Triple Negative Breast Neoplasms

HER2-negative Breast Cancer

Breast Neoplasms

Lymphoma, T-Cell, Peripheral

Esophageal Neoplasms, Stomach Neoplasms

Small Cell Lung Cancer Extensive Stage

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Stomach Neoplasms

Breast Neoplasms, Inflammatory Breast Neoplasms

Upper Tract Urothelial Carcinoma

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Stomach Neoplasms

Hodgkin Disease, Lymphoma

Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Breast Neoplasms

Breast Carcinoma In Situ, Carcinoma, Lobular, Inflammatory Breast Neoplasms

Triple Negative Breast Neoplasms

Breast Neoplasms, Inflammatory Breast Neoplasms

Breast Neoplasms

Stomach Neoplasms

Prostatic Neoplasms

Clinical Trials

NeoTENNIS

Zanubrutinib Combined With R-CHOP Regimen in the Treatment of Newly Diagnosed DLBCL With High-risk Factors

The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train.

A Phase II Study Evaluating the Efficacy and Safety of Pembrolizumab in Combination With Chemotherapy as Neoadjuvant Therapy for Triple-negative Breast Cancer

HIFU

A Study of Immunotherapy Combined With Neoadjuvant Therapy Versus Neoadjuvant Therapy for Breast Cancer

DDP

Clinical Study of Chidamide Combined With Chemotherapy in Neoadjuvant Treatment of HR+/ HER2-BC

Pyrotinib as Neoadjuvant Agent for Non-objective Response HER2-positive Early Breast Cancer

Neoadjuvant Study of Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (TNBC)

Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast Cancer

PRETTY

A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma

SEED

SHR-1210 Combined With Epirubicin in the Treatment of Extensive Disease Small Cell Lung Cancer

SHH-CM

Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive Breast Cancer

Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer

NCT-B4

PROMIX

Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas

A Study on Neoadjuvant Therapy for Her-2 Positive Breast Cancer and the Prognosis by Detecting CTCs

Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer

A Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patients

Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer

SIEG

Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection

High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma

Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer

NACprotocol

Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

Combination Chemotherapy in Treating Women With Resected Breast Cancer

Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach

A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer